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Abstract
Tumor-associated macrophages are known to influence cancer progression by modulation of immune function,
angiogenesis, and cell metastasis, however, little is known about the chemokine signaling networks that regulate this
process. Utilizing CT26 colon cancer cells and RAW 264.7 macrophages as a model cellular system, we demonstrate that
treatment of CT26 cells with RAW 264.7 conditioned medium induces cell migration, invasion and metastasis. Inflammatory
gene microarray analysis indicated CT26-stimulated RAW 264.7 macrophages upregulate SDF-1a and VEGF, and that these
cytokines contribute to CT26 migration in vitro. RAW 264.7 macrophages also showed a robust chemotactic response
towards CT26-derived chemokines. In particular, microarray analysis and functional testing revealed CSF-1 as the major
chemoattractant for RAW 264.7 macrophages. Interestingly, in the chick CAM model of cancer progression, RAW 264.7
macrophages localized specifically to the tumor periphery where they were found to increase CT26 tumor growth,
microvascular density, vascular disruption, and lung metastasis, suggesting these cells home to actively invading areas of
the tumor, but not the hypoxic core of the tumor mass. In support of these findings, hypoxic conditions down regulated
CSF-1 production in several tumor cell lines and decreased RAW 264.7 macrophage migration in vitro. Together our findings
suggest a model where normoxic tumor cells release CSF-1 to recruit macrophages to the tumor periphery where they
secrete motility and angiogenic factors that facilitate tumor cell invasion and metastasis.
Citation: Green CE, Liu T, Montel V, Hsiao G, Lester RD, et al. (2009) Chemoattractant Signaling between Tumor Cells and Macrophages Regulates Cancer Cell
Migration, Metastasis and Neovascularization. PLoS ONE 4(8): e6713. doi:10.1371/journal.pone.0006713
Editor: Derya Unutmaz, New York University School of Medicine, United States of America
Received May 22, 2009; Accepted July 9, 2009; Published August 21, 2009
Copyright:  2009 Green et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: C.E.G, T.L. and R.L.K are supported by NIH grants R01CA097022 and R01GM068487. V.M., R.D.L and S.L.G. are supported by NIH grant R01CA94900. G.H.
and S.S. are supported by NIH grant R01GM078005. www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: rklemke@ucsd.edu
¤ Current address: Novocell, Inc., San Diego, California, United States of America
Introduction
The propensity for tumors to progress and metastasize reflects
not only the oncogenic mutations in the cancer cells but also
dynamic interactions involving non-malignant cells in the tumor
cell microenvironment. Non-malignant cells that infiltrate a
developing cancer include fibroblasts, adipocytes, endothelial cells,
perivascular cells, and immune cells, all of which may contribute
to cancer progression [1]. Amongst the immune cells, macro-
phages have been shown to play a supportive role, promoting
tumor cell survival, proliferation, and metastasis [2]. Tumor-
associated macrophages (TAMs) are derived from circulating
peripheral blood monocytes that are attracted to the tumor
vasculature where they extravasate into the interstitium and
differentiate [3]. Although homing of macrophage to tumors is
poorly understood, tumor cells are known to release macrophage
chemoattractants including CCL2, CCL5, CCL7, CCL8,
CXCL12, VEGF and CSF-1 [4]. Compared to classically
activated macrophages (M1) that function as primary effector
cells in the innate immune system, M2 TAMs support tumor
survival by promoting local angiogenesis and tissue remodeling,
while suppressing the immune response [5]. TAMs localize to the
invasive areas of the tumor where they secrete a variety of
cytokines and proteases involved in tumor cell invasion and
metastasis [6,7]. In this role, TAMs actively contribute to tumor
progression and the transition to malignancy that often correlates
with poor clinical outcome. However, deciphering the tumor-cell
chemokine networks that regulate cancer progression in vivo
remains a major challenge.
Angiogenesis, which is critical for cancer progression, is
controlled by a variety of factors known to stimulate blood vessel
growth and/or maturation, including VEGF, TGF-b, EGF, bFGF
and TNF-a. TAMs represent a primary source of many of these
angiogenic proteins in the tumor microenvironement [8,9,10]. In
particular, VEGF is released by TAMs and is a potent stimulus for
the growth of new blood vessels, increased microvascular density,
vascular disruption, and leak [11]. Bloodvesselsthat areundergoing
remodeling are porous and fragile and thus more susceptible to
tumor cell intravasation [12]. Therefore, at the invasive front,
TAMs may promote tumor metastasis by stimulating the formation
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to tumor cell intravasation, while simultaneously activating cancer
cell migration and invasion by releasing a variety of chemokines,
mitogens and proteases.
In addition to the invasive front, TAMs may also localize to the
avascular hypoxic core of the tumor [13,14]. VEGF is released by
TAMs in the tumor core in response to hypoxia and stabilization
of HIF1a and HIF2a [15,16]. VEGF may also be involved in
recruiting TAMs to the tumor core, in addition to other poorly
defined factors present in the cellular debris resulting from tumor
necrosis [13]. Once localized to the core, TAMs may not only
clear cellular debris but also regulate neovascularization and
tumor survival. Thus, there are subsets of TAMs that are
differentially distributed in the tumor microenvironment that
may serve specialized roles during cancer progression [2]. We
hypothesize that tumor oxygenation is a major determinant of
macrophage activity in cancers. For example, in the hypoxic
tumor core, TAMs may be primarily angiogenic and phagocytic,
whereas under normoxic conditions at the tumor periphery,
TAMs may contribute to tumor metastasis by increasing tissue
remodeling and vascular density. In the latter case, VEGF release
by TAMs may be regulated independently of hypoxia through
interactions with invasive tumor cells or stromal cells.
Understanding the role of TAMs in cancer progression in vivo is
complicated by the in ability to decipher the multitude of factors
present in the microenvironment of the tumor. Therefore, model
systems that recapitulate in vivo tumor cell-TAM interactions in vitro
are necessary to help unravel the complexities of tumor
progression and metastasis under defined conditions. In the
present study, we developed a model system to directly investigate
cytokine signaling between CT26 colon cancer cells and RAW
264.7 macrophages. Using this unique model system, we
demonstrate that RAW 264.7 macrophages and CT26 tumor
cells are mutually attracted to one another and that macrophages
induce a highly migratory and protrusive phenotype in the tumor
cells. Inflammatory gene array analysis and functional testing
revealed that tumor cell-derived CSF-1 is the major chemoat-
tractant for RAW 264.7 macrophages whereas macrophage
derived SDF-1a and VEGF contribute to CT26 cancer cell
invasion. Further, a total of 270 genes in RAW 264.7 macrophages
and 85 genes in CT26 tumor cells were up- or down-regulated
during incubation in conditioned media, suggesting that additional
pathways beyond those tested are likely activated during
bidirectional signaling. In chick CAMs inoculated with tumor
cells, RAW 264.7 macrophages localize to the tumor periphery,
where they facilitate vascular remodeling and potentiate tumor cell
metastasis to the chick lungs. These results support a model in
which paracrine signaling between tumor cells and macrophages
regulates the localization of macrophages within the tumor and the
propensity of the tumor cells to metastasize.
Materials and Methods
Cell lines, reagents and antibodies
CT26 mouse colon cancer line, RAW 264.7 mouse macrophage
line and MDA-MB-468 breast cancer line were obtained from
American Type Culture Collection (ATCC, Manassas, VA). CL16,
a metastatic variant of MDA-MB-435, was derived as previously
described [17]. CT26 cells were maintained in RPMI 1640
supplemented with 10% FBS, 1% penicillin-streptomycin (Invitro-
gen, Carlsbad CA) and 1% glutamine. RAW 264.7, MDA-MB-468
and CL16 cells were cultured in DMEM (Invitrogen, Carlsbad CA)
supplemented with 10% FBS, 1% penicillin-streptomycin and 1%
glutamax (Invitrogen, CA). RAW 264.7 expressing GFP were made
by infecting cells with Lenti-Green supernatant (BioGenova,
Rockville, MD). The highest 0.1% expressing cells were then sorted
byFACS. CT26 cellsexpressing DsRed weregenerated byinfecting
cells with the lentivirus, pEF1-DsRed-pur, followed by selection in
puromycin (1 mg/ml). Where indicated, cells were treated with
blocking anti-CSF-1R mAb (AFS98, eBioscience, San Diego, CA),
blocking anti-EGF-R (Millipore, Billerica, MA), recombinant
mouse CSF-1 (R&D Systems, Minneapolis, MN), recombinant
mouse EGF (R&D Systems, Minneapolis, MN), recombinant
mouse SDF-1a (Millipore, Billerica, MA) or recombinant
VEGF165 (Millipore, Billerica, MA).
Quantitative cell migration and invasion assays
For time-lapse imaging of cell migration in co-culture, RAW
264.7-GFP were incubated on fibronectin (10 mg/ml, Sigma-
Aldrich) coated Lab-Tek chamber slides (Nunc, Rochester, NY)
for 30 min at 37uC prior to addition of CT26-DsRed (10
7 cells/
ml). Once CT26 were added, the chamber slide was immediately
placed in an Inc-2000 Incubator System (20/20 Technology Inc.,
Wilmington, NC) then imaged at 20X (NA=0.75) for 15 hrs at 4
frames/hr using a Nikon C1-Si inverted confocal microscope
(Nikon Instruments Inc., Melville, NY) equipped with PMT
detectors and lasers appropriate for GFP (488 nm) and DsRed
(561 nm). Descanned images were acquired using Nikon EZ-C1
software then rendered for cell tracking and shape analysis using
Imaris (Bitplane, Saint Paul, MN). Upon adhesion, the location
coordinates of centroids for individual CT26-DsRed cells were
recorded at each frame over the timecourse of migration. These
coordinates were then used to create migration tracks from which
the migration straightness, displacement and total distance were
determined. Migration straightness is unitless value that relates the
number of branch points or turns in a track to the total migration
distance. Total migration path length was determined by summing
migration step distances every frame throughout the video
sequence. Net migration path displacement was quantitated as
the direct distance between the start of migration and the end of
migration. The shape index is the ratio of the major axis length
over the minor axis length for individual cells tracked over the
timecourse of the migration.
Chemotaxis assays were performed as previously described with
minor modifications [18]. Briefly, modified Boyden chambers
(Transwell, 6.5 mm diameter; Corning, Lowell, MA) containing
polycarbonate membranes with 8 mm pores were coated on both
sides with fibronectin (10 mg/ml, Sigma-Aldrich) for 2 h at 37uC,
rinsed once with PBS, and then placed into the lower chamber
containing 500 ml migration adhesion buffer (MAB; DMEM with
0.1% RIA-grade fraction V BSA (Sigma-Aldrich), 1% penicillin-
streptomycin and 1% glutamine), complete media (DMEM
supplemented with 10% FBS, 1% penicillin-streptomycin and
1% glutamine), conditioned media or migration buffer containing
SDF-1a (100 ng/ml), VEGF165 (10 ng/ml), EGF (100 ng/ml) or
CSF-1 (40 ng/ml), as indicated. Conditioned medias were
collected from CT26 or RAW 264.7 cultures following 48 hrs of
incubation at 37uC. Dilutions of conditioned medias were made in
appropriate base culture media. Where indicated, anti-CSF-1R
(20 mg/ml) and anti-EGF-R (20 mg/ml) were present in both top
and bottom wells throughout the assay. Serum-starved RAW
264.7 or CT26 cells were removed from culture dishes with
Hanks’ balanced salt solution containing 5 mM EDTA and
25 mM Hepes, pH 7.2, and 0.01% trypsin, washed twice with
migration buffer, and then resuspended in migration buffer at
10
6 cells/ml. 10
5 cells in 100 ml migration buffer were then added
to the top of each migration chamber and allowed to migrate to
the underside of the porous membrane for various times in
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CT26 migrated for 3 hrs in all conditions. The nonmigratory cells
on the upper membrane surface were removed with a cotton swab,
and the migratory cells attached to the bottom surface of the
membrane stained with 0.1% crystal violet in 0.1 M borate,
pH 9.0, and 2% ethanol for 20 min at room temperature. The
number of chemotaxing cells per membrane was counted using an
inverted phase contrast microscope at 40X. For RAW 264.7
chemotaxis under hypoxic conditions, the lower chamber was
supplemented with complete DMEM containing 10% FBS to
create a chemotactic gradient. RAW 264.7 were then allowed to
migrate for 24 hrs under normoxic (21% oxygen) or hypoxic (1%
oxygen) conditions using an IsoTemp incubator (Fisher Scientific,
Pittsburgh, PA). Migratory cells were fixed with 100% methanol
for 5 min and stained with 0.1% crystal violet in 0.1 M borate,
pH 9.0, 2% ethanol for 20 min. Membranes were cut from the
Transwell and placed in 200 mL of 10% acid acetic to elute the
stain then absorbance was read at 570 nm.
To examine macrophage invasion into collagen, CT26-DsRed
or red fluorescent (580 nm excitation/605 nm emission) polysty-
rene microspheres (10 mm; Molecular Probes, Carlsbad, CA) were
embedded in sterile filtered type 1 collagen gel (PureCol; Nutacon,
Leimuiden, The Netherlands) containing 1X RPMI (Sigma-
Aldrich), 25 mM sodium bicarbonate and adjusted to pH 7.4
using 0.1 M sodium hydroxide, as previously described [19]. The
collagen solution containing CT26-DsRed (10
7 cells/ml) or beads
(10
7 beads/ml) was allowed to gel in 10 ml aliquots on fibronectin
(10 mg/ml, Sigma-Aldrich) coated Lab-Tek chamber slides (Nunc,
Rochester, NY) for 30 min prior to addition of RAW 264.7-GFP
(10
5 cells/ml). Initial migration of RAW 264.7-GFP at the
interface with the collagen drop was imaged at 20X (NA=0.75)
for 12 hrs at 4 frames/hr using a Nikon C1-Si inverted confocal
microscope (Nikon Instruments Inc., Melville, NY) equipped with
PMT detectors and lasers appropriate for GFP (488 nm) and
DsRed (561 nm). Descanned images were acquired using Nikon
EZ-C1 software then rendered for cell tracking using Imaris
(Bitplane, Saint Paul, MN). Location coordinates of centroids for
individual RAW 264.7-GFP were recorded at each frame over the
timecourse of migration. These coordinates were then used to
calculate the displacement and total distance migrated for cells
within and beyond 100 mm of the collagen drop boundary. Slides
were incubated for an additional 7 days then imaged using
confocal microscopy (10X; NA=0.45) at 1 mm increments
throughout the entire Z-axis of the collagen drop.
Chicken CAM Assay
The chick embryo metastasis assay was performed as previously
described [20,21]. Briefly, CT26-DsRed (2610
6 cells) alone or
combined with RAW 264.7-GFP (2610
5 cells) cells were suspended
on ice in Matrigel (BD Bioscience) then inoculated onto the chick
chorioallantoic membrane (CAM) on developmental day 9. After 11
days, on developmental day 20, embryos were sacrificed and primary
tumors were removed, imaged at 0.63X and 2X by stereomicroscopy,
weighed and measured for diameter. The heart and lungs were
isolated, and cell dissemination was quantified by counting cell clusters
using confocal microscopy at 10X (NA=0.45) with a step distance of
1 mm. Tumors were subsequently sectioned and placed directly onto a
glass coverslip for imaging by confocal microscopy (10X; NA=0.45).
Tumors were imaged 0 to 0.5 cm from the periphery or edge (tumor
periphery), 0.5 cm to 1 cm from the periphery (tumor wall) and
1.0 cm to 3 cm from the tumor periphery (tumor core). Quantitation
of RAW 264.7-GFP distribution within the CT26-DsRed tumors was
determined by averaging GFP pixel bit maps over a field of view to
produce a mean fluorescence intensity for each region of the tumor
using Image Pro Plus v4.5 (Media Cybernetics, Bethesda, MD).
Brightness and contrast adjustments were made equally to all channels
and did not modify the relative differences between GFP pixel
intensity in various regions of the tumor.
qPCR
CT26, MDA-MB-468 or CL16 tumor cells were incubated at
37uC in the appropriate complete medium for 24 hrs under
hypoxic (1.0% oxygen) or normoxic (21% oxygen) conditions.
Total RNA was then extracted using TRIzol (Invitrogen,
Carlsbad, CA), according to the manufacturer recommendations.
cDNA was synthesized from 2 mg of total RNA using the iScript
cDNA synthesis kit (Bio-Rad Laboratories, Hercules, CA). qPCR
was performed using a System 7300 instrument (Applied
Biosystems, Foster City, CA) and a one-step program: 95uC,
10 min; 95uC, 306,6 0 uC, 1 min for 40 cycles. CSF-1 and
GAPDH mRNA levels were measured in triplicates and
normalized against HPRT-1 mRNA.
Microarray analysis
To examine inflammatory gene expression, conditioned buffers
were collected from CT26 or RAW 264.7 cultures following 48 hrs of
incubation at 37uC and applied to cultures of the opposing cell type
for 24 hrs. mRNA was then isolated using the RNeasy kit (Quiagen,
Valencia, CA), reverse transcribed using the iScript cDNA synthesis
kit (Bio-Rad Laboratories, Hercules, CA) and analyzed in triplicate
by hybridization to the Codelink Mammalian Inflammation Bioarray
containing single stranded 30-mer oligonucleotide probes (GE
Healthcare, Piscataway, NJ), according to the manufacturer
recommendations. Raw gene expression for replicates was averaged
and normalized using the CodeLink Gene Expression Analysis v5.0
Software (GE Healthcare, Piscataway, NJ). To determine statistically
significant upregulation or downregulation of gene transcripts, we
applied the Variance Modeled Posterior Inference with Regional
Exponentials (VAMPIRE) microarray analysis web suite to raw
transcript expression values, as previously described [22,23]. Group-
wiseerrorassociatedwithmultiplecomparisonswascorrected usinga
conservative Bonferroni corrected threshold of 5% (alpha=0.05).
Hierarchical clustering of standardized array data was performed
using dChip (distance: correlation, linkage: centroid) based on the
gene ontology annotations for angiogensis, cell proliferation and
chemotaxis [24]. For heatmap analysis, intensity scores were
calculated based on the significance of gene up- or down-regulation,
as determined by VAMPIRE analysis. These genes were then
organized based on the gene ontology annotations for angiogensis,
cell proliferation and chemotaxis using dChip (distance metric:
correlation, linkage method: average).
Statistical analysis
Data analysis was performed using GraphPad Prism version 4.0
software (GraphPad Software, San Diego, CA.). All data are reported
as mean6SE. Nonparametric group data were analyzed by analysis
of variance (ANOVA) and the Neuman-Keuls post-test. Gaussian-
distributed mean values were analyzed by Student t test. Group
comparisons were deemed significant for 2-tailed P values below .05.
Results
Migration and Morphological Analysis of CT26 Cancer
Cells Co-Cultured with RAW 264.7 Macrophages
We first performed a kinematic analysis of tumor cell migration
behavior and determined cell shape changes in response to co-
culture with macrophages. To directly examine how macrophages
alter the migratory behavior and persistence of colon cancer cells,
Tumor Regulation by Macrophage
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microscopy during co-culture for 15 hrs in the presence or absence
of RAW 264.7 mouse macrophages (Fig. 1A). CT26 cells alone
exhibited an overall migration length of 199678 mm (average6SD)
(Fig. 1B). This value was indistinguishable from CT26 co-cultured
with RAW 264.7 cells, which exhibited a migration length of
154646 mm. However, despite similar migration lengths, CT26
that were co-cultured with RAW 264.7 cells migrated along a
significantly straighter path, with straightness values of 0.34 for
CT26 co-cultured with RAW 264.7 cells compared with 0.15 for
CT26 alone (Fig. 1B). This 2-fold increase in straightness was
accompanied by a significant increase in overall displacement or
persistence of migrationbyCT26 cellsco-cultured withRAW264.7
cells. CT26 cells co-cultured with macrophages exhibited an
average displacement of 49624 mm compared with 28620 mm
for CT26 cells alone (Fig. 1B). These findings suggest that the RAW
264.7 macrophages promote the migration of CT26 cells in vitro.
Importantly, CT26 cells cultured with or without macrophages
showed similar viability. In fact, analysis of tumor cell growth over
several days indicated that the CT26 cells grew faster in the
presence of macrophages (results not shown). Co-culturing of RAW
264.7 cells with CT26 cells did not change RAW 264.7 cell
adhesion to extracellular matrix proteins. Furthermore, evaluation
of RAW 264.7 cell behavior in this assay did not reveal significant
differences in migration distance, displacement, straightness, or cell
shape when the cells were co-cultured with CT26 cells (results not
shown), suggesting the absence of chemical gradients sufficient for
macrophage chemotaxis. Together, these findings indicate that
RAW 264.7 macrophages induce persistent CT26 cancer cell
migration on 2-D surfaces.
The ability of cancer cells to form invadapodia and membrane
protrusions has been linked to increased migration and tissue
invasiveness [25]. Therefore, we examined CT26 cell morphology
in response to co-culturing with RAW 264.7 macrophages. Within
6 hrs, co-culturing with the RAW 264.7 macrophages promoted
an enhanced mesenchymal phenotype in the CT26 cells,
characterized by numerous long membrane protrusions that
radiated outward from the cell body (Fig. 2A). This morphology
was sustained for greater than 12 hrs and was evident in all CT26
cells within the co-culture that were in contact with one or more
macrophages (Fig. 2B). To determine the minimum time required
for RAW 264.7 cells to elicit CT26 morphology changes, we
measured the kinetics of shape change (Fig. 2C). Beginning with
initial adhesion of cells to the dish, the major and minor axes of
migrating CT26 cells were determined every 20 min throughout
12 hrs of culture with or without RAW 264.7 cells using a
chamber slide and confocal microscopy. As anticipated, CT26
cells alone or in co-culture were effectively round upon initial
adhesion to the dish with shape indices of ,1. CT26 cells
incubated with RAW 264.7 cells underwent rapid cell elongation,
as the major axis along the polarized membrane extensions was
,4-fold longer than the minor axis as early as 4 hrs following
initial cell adhesion compared with cells cultured in the absence of
RAW 264.7 macrophages (Fig. 2C). The shape change reached a
plateau at ,5.5 after 8 hrs of co-culture. As expected, CT26 cells
that were cultured alone also exhibited an initial increase in shape
extension as they adhered and spread. However, in this case, the
cells only extended short protrusions and failed to elongate
significantly, as the shape index only reached a maximum of ,2
after 6 hrs of culturing (Fig. 2C). Taken together, quantitative
analysis of CT26 cell migration and morphology dynamics
indicate that RAW 264.7 macrophages elicit a rapid and sustained
increase in cell migration that is associated with increased
formation of membrane protrusions.
RAW 264.7 Macrophages and CT26 Tumor Cells Release
Soluble Chemotactic Factors that Promote Reciprocal
Chemotaxis
We next examined whether induction of an invasive phenotype
in CT26 cells by RAW 264.7 cells was due to a direct interaction
with the macrophages or a response to soluble chemotactic factors
released by the macrophages using a standard Boyden chamber
Figure 1. Macrophages elicit directed migration of colon
cancer cells in vitro. A,B) CT26-DsRed (10
5/ml) were incubated on
fibronectin with RAW 264.7-GFP (10
5/ml), as indicated, for 12 hrs at
37uC. During this time, the straightness, total length traveled and total
cumulative displacement of individual CT26 cell centroids were tracked
(yellow lines) at 4 frames/hr in the presence and absence of RAW 264.7
macrophages using confocal microscopy at 20X. Data is presented as
individual track quantitation for 55–75 cells over 3 experiments, with
average indicated by bar. Magnification scale bar represents 30 mm. *
denotes significant difference in migration path straightness
(p,0.0001). ** denotes significant difference in migration path
displacement (p,0.0001).
doi:10.1371/journal.pone.0006713.g001
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chemotactic response towards a gradient of RAW 264.7 cell
conditioned media (CM), whereas exposure to control basal
medium alone did not induce a migratory response (Fig. 3A).
Importantly, cell migration was predominantly directional toward
the concentration gradient, as tumor cell migration was reduced
by ,60% when RAW 264.7 cell CM was added uniformly to both
top and bottom chambers (Fig. 3A). These findings indicate that
RAW 264.7 macrophages release soluble factors that promote
directional migration of CT26 colon cancer cells.
Figure 2. Colon cancer cells exhibit elongated protrusions when cultured with macrophages in vitro. DsRed-CT26 (10
5/ml) were
incubated on fibronectin with GFP-RAW 264.7 (10
5/ml), as indicated, for 15 hrs at 37uC. Fluorescent images were acquired using confocal microscopy
(20X) at 4 frames/hr. A) Time course of Ds-Red-CT26 dynamics over 12 hrs when incubated alone or with RAW 264.7-GFP macrophages. Images are
representative of CT26 movement over 3 separate experiments. Magnification scale bar represents 20 mm. B) Cumulative CT26-DsRed distribution
and protrusion after 15 hrs of incubation alone (right) or with RAW 264.7-GFP macrophages (left and center, with green channel turned off). Images
are representative of 3 separate experiments. Magnification scale bar represents 30 mm. C) The shape index (major axis/minor axis) of CT26 cells in the
presence or absence of RAW 264.7 cells was tracked over 12 hrs of migration. Data represents the average6SEM for 10 cells over 3 separate
experiments.
doi:10.1371/journal.pone.0006713.g002
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5/ml) were added to the upper of a Boyden chamber
with RAW 264.7 conditioned media, control buffer or complete DMEM added to the lower well. CT26 were allowed to migrate for 3 hrs at 37uC prior
to staining and quantitation of chemotaxis. Data represents the average6SEM for 15–30 randomly selected fields over 3–6 separate experiments. *
denotes significance between 50% RAW CM and media control (p,0.001) and 50% RAW CM and 100% RAW CM top/bottom (p,0.001). B) RAW 264.7
(10
5/ml) were added to the upper well of a Boyden chamber with CT26 conditioned media, control buffer or complete DMEM added to the lower
well. RAW 264.7 were allowed to migrate for 24 hrs at 37uC prior to staining and quantitation of chemotaxis. Data represents average6SEM for 15–30
randomly selected fields over 3–6 separate experiments. ** denotes significance between 25% CT26 CM and media control (p,0.001) and 25%
CT26 CM and 100% CT26 CM top/bottom (p,0.001). C) GFP-RAW 264.7 (10
5/ml) were incubated on fibronectin coated chamber slides with 10 ml
collagen drops containing Ds-Red-CT26 (10
7/ml) or 10 mm red fluorescent beads (10
7/ml). Macrophage invasion into the tumor embedded or bead
embedded collagen drop was imaged after 7 days at 10X by confocal microscopy. Side view and top view images are representative of the average
macrophage response over 6 collagen tumors. Magnification scale bar for top view images represents 200 mm. D) The interface between
macrophages and the collagen tumor drop was imaged using confocal microscopy (20X) for 12 hrs at 4 frames/hr following addition of RAW 264.7 to
the chamber slide. Over this time, the dynamics of macrophage migration was quantitated by tracking individual cell centroids at 4 frames/hr.
Macrophages initiating migration within 100 mm of the tumor boundary (dashed white line) exhibit yellow tracks. Macrophages initiating migration
beyond 100 mm of the tumor boundary exhibit white tracks. Image is representative of the average macrophage response to 6 separate collagen
tumors. Magnification scale bar represents 30 mm. E) Track displacement and total track length was quantitated for macrophage migration within and
beyond 100 mm of the collagen tumor boundary. Data represents the average6SEM for 15 macrophages within 100 mm and 15 macrophages
beyond 100 mm of the collagen tumor boundary. #denotes a significant difference in migration path displacement (p,0.05). ##denotes a
significant difference in total migration path length (p,0.0001).
doi:10.1371/journal.pone.0006713.g003
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dependent chemotactic response to a gradient of CT26 cell CM
(Fig. 3B). Indeed, the extent of cell migration to undiluted CM was
,10-fold greater than basal levels of migration observed in
response to either serum-containing medium or migration buffer
containing only bovine albumin. RAW 264.7 cell migration was
highly directional and not due to random chemokinetic movement
as adding CT26 CM to both the upper and lower chambers
completely abrogated the migration response (Fig. 3B). Interest-
ingly, in contrast to the co-culture system where RAW 264.7 did
not exhibit an increase in migration distance or displacement, the
gradient of chemotactic factors in the Boyden chamber was
sufficiently steep to elicit robust chemotaxis of RAW 264.7
macrophages.
To further investigate macrophage chemotaxis towards tumor
cells, we developed a novel 3D migration assay in which CT26
cells were embedded in collagen gel and place drop-wise on a
coverslip with RAW 264.7 cells distributed evenly along the
periphery of the gel matrix. RAW 264.7 cell migration and
invasion at the gel margin was tracked and quantitated using
confocal microscopy and imaging software during the initial
12 hrs and after 7 days. By this approach, RAW 264.7
macrophages actively invaded the collagen gel only when tumor
cells were present (Fig. 3C). The invasion was directional toward
the tumor cells since RAW 264.7 cells showed little ability to
invade collagen gels embedded with rhodamine-labeled beads in
the absence of cells (Fig. 3C). Quantitation of the number of
macrophages per microscopic field indicated an ,8-fold increase
in macrophage invasion when tumor cells were present in the
collagen compared to beads alone (data not shown). These results
demonstrate that CT26 cell-derived soluble attractants are
required for RAW 264.7 cell chemotaxis and that adhesive
interactions with the matrix alone are not haptotactic for
macrophages in this model. Interestingly, RAW 264.7 macro-
phages at the tumor periphery showed changes in migration
behavior within 12 hrs of being added to the tumor cell/collagen
gels (Fig.3D, E). In fact, RAW 264.7 cells within ,100 mm (yellow
tracks) of the collagen/CT26 border exhibited a ,60% reduction
in the total distance of migration suggesting a decrease in random
movement. Moreover, total displacement of this subpopulation
was reduced by ,50%, further supporting a decrease in random
movement. Most importantly, track analysis indicated that RAW
264.7 cells within ,100 mm rarely migrated away from the tumor.
In contrast, RAW 264.7 cells beyond ,100 mm (white tracks) of
the tumor border exhibited rapid chemokinetic movement with no
persistent, directional path (Fig. 3D, E). These data and the
Transwell migration data indicate that CT26 tumor cells secrete
potent chemotactic factors that attract macrophages. These
findings are interesting in light of the fact that we did not detect
changes in the migration behavior of RAW 264.7 cells when co-
cultured directly with CT26 cells. Under these conditions it is
likely that the CT26 cell-derived factors may not provide a suitable
and stable gradient to direct RAW 264.7 cell migration.
Alternatively, direct contact of RAW 264.7 cells with tumor cells
may prevent chemotactic movement. Collectively, the data
indicates that both RAW 264.7 macrophages and CT26 tumor
cells release soluble chemoattractants that promote directional cell
migration.
Changes in Gene Expression Profiles Induced by Co-
Culturing RAW 264.7 Macrophages and CT26 Colon
Cancer Cells
While recent evidence indicates that TAMs promote tumor
growth and metastasis and suppress the normal anti-tumor
immune response, the mechanisms that regulate this complex
process remain poorly understood [2,26]. The results presented
here support a model in which tumor cells and macrophages
rapidly adopt a chemotactic phenotype due to soluble cytokines
released by the opposing cell type. To elucidate critical mediators
that may be involved, we examined expression of 854 inflamma-
tory pathway genes by CT26 cancer cells and RAW 264.7 cells
after exposure to migration buffer conditioned by the opposing cell
type. Briefly, RAW 264.7 macrophages or CT26 tumor cells were
cultured in migration buffer (media with BSA rather than serum)
for 24 hrs to generate conditioned buffer (CB). RAW 264.7 cell
CB was then added to cultures of serum-starved CT26 cells.
Likewise, CT26 cell CB was added to cultures of serum-starved
RAW 264.7 macrophages. Following incubation for 24 hrs in CB,
mRNA was isolated and analyzed using the CodeLink Mamma-
lian Inflammation Bioarray. Significant differences in gene
expression were determined using VAMPIRE (Variance-Modeled
Posterior Inference of Microarray Data), a Bayesian statistical
method that models the dependence of measurement variance on
the amplitude of gene expression [22,23]. Rather than the a priori-
determined fold-change cutoff as a means of examining signifi-
cance of up- or downregulated gene expression, VAMPIRE
accounts for the experimental false positive error rate and the
relationship between signal variance and gene expression to
determine a more statistically accurate model of differential gene
expression. Moreover, the fold-change cutoff method alone as a
differential expression test does not account for signal variance and
offers no associated level of confidence [27]. Using this approach,
RAW 264.7 macrophages that were exposed to CT26 cell CB
upregulated 244 genes and downregulated 26 genes based on fold-
change cutoffs of 1.2 and 0.27, respectively (Supplemental Table
S1). CT26 tumor cells that were exposed to RAW 264.7 cell CB
upregulated 69 genes and downregulated 16 genes with fold-
change cutoffs of 1.4 and 0.005, respectively (Supplemental Table
S2). Hierarchical clustering and annotation of differentially
expressed transcripts indicates gene signatures associated with a
variety of ontology groups, including cell proliferation, chemotax-
is, and angiogenesis for both CT26 and RAW 264.7 in
conditioned buffers (Supplemental Figs. S1A–D and S2A–D). A
partial list of the most highly up- or down-regulated genes from
these groups, as well as genes relevant to this model, is presented in
Table 1 and Table 2. For example, RAW 264.7 cells stimulated
with tumor cell CB up-regulated several angiogenic factors
(VEGF-A, HIF1a and TGF-b) and chemoattractants (CXCL12
and CXCL2) (Table 1). It is notable that upregulation of CD14,
TGF-b, CCR1, IL-18 and CXCL12 have previously been
associated with the phenotypic profile of TAMs [5,28]. Genes
downregulated include uPA, lymphotoxin B, CCL4, MMP-2 and
TNF-a (Table 1). Among these, TNF-a is reported to be poorly
expressed in TAMs and may be pro-apoptotic to tumor cells [5].
Taken together, CT26 CB stimulates RAW 264.7 macrophages to
produce proliferative, angiogenic and motility factors which may
impact cancer progression.
CT26 cells also exhibited relevant changes in chemokine
profiling when incubated with RAW 264.7 CB (Table 2).
Impacted genes include VCAM-1, VEGF-A, TGF-b and CXCL1,
all of which are reported to be indicative of a metastatic phenotype
[29,30,31,32]. In addition, GM-CSF, matrix metalloproteinase
(MMP)-10, and the chemokines CXCL10, CCL2, CCL20 and
CXCL2 were also up-regulated (Table 2). Most notably, CT26
cells upregulated CSF-1 ,2.6-fold in response to RAW 264.7 cell
CB. CSF-1 has been shown to be a major chemoattractant for
macrophages, linked to TAM regulation of cancer progression in
animals [33,34]. Taken together, the chemokine expression profile
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signatures predictive of immune modulation, angiogenesis and
increased tumor cell and macrophage migration.
SDF-1a, VEGF and CSF-1 are Key Regulators of Tumor Cell
and Macrophage Chemotaxis
We next sought to determine the primary macrophage-derived
chemokines responsible for inducing tumor cell migration. Although
many of the chemokines released by RAW 264.7 cells may
contribute to tumor cell migration, we chose to investigate SDF-1a
and VEGF since previous reports have linked these factors to cancer
malignancyandbothfactorsweresignificantlyup-regulated inRAW
264.7 cells exposed to CT26 CB [35,36]. Though absent in the
microarray, we also investigated the role of EGF in this response
because release of this growth factor by TAMs has previously been
linked to cancer cell migration in vitro and in vivo [34,37]. However,
EGF failed to induce CT26 migration (Fig. 4A). Moreover, function
blocking anti-EGF-R antibodies failed to block CT26 cell migration
in response to RAW 264.7 cell CB (Fig. 4A). Thus, CT26 cell
migration in response to RAW 264.7 CB is due to soluble factors
other than EGF. Similarly, neither SDF-1a nor VEGF induced
CT26 cell migration above basal levels when added separately to the
migration chamber. However,when cells werestimulated with SDF-
1a and VEGF simultaneously, tumor cell migration was increased
,2-fold compared to SDF-1a or VEGF alone (Fig. 4B). Despite this
increase,chemotaxistoSDF-1aandVEGFincombination is,35%
less than chemotaxis to RAW 264.7 conditioned media, suggesting
that other unidentified RAW 264.7-derived factors likely contribute
to CT26 chemoattraction. Indeed, many known chemoattractants
that may also be involved in CT26 migration are among the 270
Table 1. Microarray analysis of inflammatory gene expression
during culture of RAW 264.7 macrophages in tumor cell
conditioned buffer.
Gene Gene Description CB/Ctrl
uPA Urokinase Plasminogen Activator 0.3
LTB Lymphotoxin B 0.6
CCL4 Chemokine (C-C motif) Ligand 4 0.6
IL8Ra Interleukin 8 Receptor, Alpha 0.6
MMP2 Matrix Metallopeptidase 2 0.6
TNF-a Tumor Necrosis Factor alpha 0.8
CCR1 Chemokine (C-C motif) Receptor 1 1.2
IL18 Interleukin 18 1.2
Vim Vimentin 1.2
RelA V-rel Reticuloendotheliosis Viral Oncogene Homolog A 1.2
CtsD Cathepsin D 1.3
TGFb1 Transforming Growth Factor, Beta 1 1.3
Casp8 Caspase 8 1.3
Arrb2 Beta 2 Arrestin 1.3
Vav1 Vav 1 Oncogene 1.3
IL16 Interleukin 16 1.4
ILK Integrin Linked Kinase 1.4
XCR1 Chemokine (C motif) Receptor 1 1.4
IL11Ra1 Interleukin 11 Receptor, Alpha Chain 1 1.4
ITGb2 Beta 2 Integrin 1.5
CXCL2 Chemokine (C-X-C motif) Ligand 2 1.6
CSF2Rb2 Colony Stimulating Factor 2 Receptor, Beta 2 1.6
IL1R-L1 Interleukin 1 Receptor-like 1 1.7
IL15Ra Interleukin 15 Receptor, Alpha Chain 1.7
NCAM1 Neural Cell Adhesion Molecule-1 1.8
VEGF-A Vascular Endothelial Growth Factor A 1.8
CD14 CD14 Antigen 1.9
CXCL12 Chemokine (C-X-C motif) Ligand 12 2.3
CT26 tumor cell conditioned buffer was applied to RAW 264.7 cells for 24 hrs
prior to mRNA isolation and analysis using the Codelink Mammalian
Inflammation Bioarray. Significance of transcript upregulation or
downregulation was determined using the VAMPIRE statistical algorithm. Data
represents the fold change in transcript expression from 3 separate
experiments. Of the 270 genes detected in RAW 264.7 cells (Supplemental Table
S1), the most highly upregulated or downregulated genes associated with
migration, proliferation and angiogenesis are presented.
doi:10.1371/journal.pone.0006713.t001
Table 2. Microarray analysis of inflammatory gene expression
during culture of CT26 tumor cells in macrophage
conditioned buffer.
Gene Gene Description CB/Ctrl
FGF10 Fibroblast Growth Factor 10 0.3
CD80 CD80 Antigen 0.6
HSP1A Heat Shock Protein 1A 0.6
SOCS1 Suppressor of Cytokine Signaling 1 0.7
CD14 CD14 Antigen 0.7
VEGF-A Vascular Endothelial Growth Factor A 1.5
RelA V-rel Reticuloendotheliosis Viral Oncogene Homolog A 1.5
TGFb3 Transforming Growth Factor, Beta 3 1.6
CXCL10 Chemokine (C-X-C motif) Ligand 10 1.6
TGFb1 Transforming Growth Factor, Beta 1 1.8
ARHGEF2 Rho/Rac Guanine Nucleotide Exchange Factor 2 1.8
RalGDS Ral Guanine Nucleotide Dissociation Stimulator 1.9
NFkBIb NFkB Inhibitor Beta 1.9
Arrb2 Beta 2 Arrestin 2.0
NFkB2 NFkB 2 2.1
Il15Ra Interleukin 15 Receptor, Alpha Chain 2.2
RelB Avian Reticuloendotheliosis Viral Oncogene Related B 2.4
CSF1 Colony Stimulating Factor 1 2.6
NFkBIa NFkB Inhibitor Alpha 2.7
VCAM1 Vascular Cell Adhesion Molecule 1 3.0
CXCL1 Chemokine (C-X-C motif) Ligand 1 3.1
CCL2 Chemokine (C-C motif) Ligand 2 3.2
MMP10 Matrix Metallopeptidase 10 3.3
CCL20 Chemokine (C-C motif) Ligand 20 3.8
NFkBIe NFkB Inhibitor Epsilon 4.8
CSF2 Colony Stimulating Factor 2 5.1
CXCL2 Chemokine (C-X-C motif) Ligand 2 6.7
INFa9 Interferon Alpha 9 9.3
RAW 264.7 conditioned buffer was applied to CT26 cells for 24 hrs prior to
mRNA isolation and analysis using the Codelink Mammalian Inflammation
Bioarray. Significance of transcript upregulation or downregulation was
determined using the VAMPIRE statistical algorithm. Data represents the fold
change in transcript expression from 3 separate experiments. Of the 85 genes
detected in CT26 cells (Supplemental Table S2), the most highly upregulated or
downregulated genes associated with migration, proliferation and
angiogenesis are presented.
doi:10.1371/journal.pone.0006713.t002
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regulated in RAW 264.7. Nonetheless, these findings indicate that
SDF-1a and VEGF work synergistically to potentiate the chemotaxis
of CT26 colon cancer cells.
Previous reports implicate CSF-1 secreted by breast cancer cells
as the exclusive chemoattractant for TAMs [33,34,37]. Gene
profiling of CT26 cancer cells also indicates upregulation of CSF-1
in the presence of RAW 264.7 cell CB. Therefore, we tested
whether CSF-1 is responsible for the increase in RAW 264.7 cell
migration in the presence of CT26 cell CB. Purified CSF-1 was
potent in eliciting RAW 264.7 cell chemotaxis (Fig. 4C). This
response was inhibited with function blocking antibodies to the
CSF-1 receptor (c-fms/CSF-1R). Likewise, anti-CSF-1R antibody
reduced RAW 264.7 cell migration to CT26 cell CB by ,85%. It
is important to note that the CSF-1 present in the CT26 cell CB
represents basal secretion, as the conditioned media was generated
by CT26 cells that had not been exposed to RAW 264.7 cells a
priori. Once CT26 cells are exposed to RAW 264.7 CB, transcript
analysis indicates that CT26 upregulate CSF-1 ,2.6-fold above
basal secretion levels (Table 1). Taken together, the data indicates
that chemotaxis of RAW 264.7 macrophages to quiescent CT26
cells is robust and occurs primarily in response to tumor cell-
secreted CSF-1, which can be further enhanced by exposure to
macrophage-derived products.
RAW 264.7 Macrophages Promote CT26 Tumor
Formation, Metastasis, Vascular Density, and Vascular
Disruption In Vivo
Our accumulative data indicate that the chemokine and growth
factor networks established between RAW 264.7 macrophages
and CT26 tumor cells results in the induction of cell migration and
the release of angiogenic factors. Next, we tested whether RAW
264.7 macrophages potentiate CT26 cancer progression in vivo.
For these studies, we utilized the common chicken egg
chorioallantoic membrane (CAM) assay which allows for the
evaluation of tumor formation, angiogenesis, and cell metastasis to
the lungs in 11 days (Lester etal JCB 2007; Kim et al Cell 1998).
CT26 tumor cells, in the presence or absence of RAW 264.7
macrophages, were suspended in Matrigel and inoculated onto the
CAM surface. After 11 days in vivo, the tumors were imaged then
excised from the CAM to assess tumor size and vascularization.
The chick lungs were also removed and the extent of tumor cell
dissemination was determined by counting the number of tumor
nodules. Strikingly, CT26 tumors that developed in the presence
of RAW 264.7 macrophages exhibited a significant increase in
tumor size, vascular density, vascular disruption and leak
compared to control CT26 tumors without RAW 264.7 cells
(Fig. 5A and B). Moreover, CT26 cell metastasis to the lungs was
increased ,2-fold in the presence of RAW 264.7 macrophages
compared to control CT26 tumors (Fig. 5A and B). CT26 cells were
not observed in the chick heart under any condition (results not
shown). The dramatic increase in small microvessel density and
the highly disorganized and disrupted nature of the vessels made
quantification of typical vascular perimeters (branch points, and
length) impossible (Fig. 5A). This vascular phenotype was observed
in greater than 80% of the CT26 tumors with RAW 264.7 cells
compared to less than 10% of control tumors. Associated with the
vascular disruption and increased tumor mass induced by RAW
264.7 cells was a ,2.5-fold increase in the ability of CT26 cells to
metastasize to the lungs (Fig. 5B). Thus, RAW 264.7 macrophages
induce a highly malignant phenotype in CT26 cells and contribute
to their dissemination to the lungs. Taken together, our in vitro and
in vivo data indicate that RAW 264.7 macrophages strongly
increase the migratory and metastatic properties of CT26 colon
Figure 4. CSF-1, VEGF and SDF-1a mediate reciprocal chemo-
taxis between macrophages and tumor cells. A) CT26 (10
5/ml)
were added to the upper of a Boyden chamber with RAW 264.7
conditioned media, 100 ng/ml EGF in migration buffer, control
migration buffer or complete DMEM added to the lower well. Anti-
EGFR was present in both the top and bottom wells, as indicated,
throughout the experiment. CT26 were allowed to migrate for 3 hrs at
37uC prior to staining and quantitation of chemotaxis. Data represents
the average6SEM for 15–30 randomly selected fields over 3–6
separate experiments. B) CT26 (10
5/ml) were added to the upper of
a Boyden chamber with 100 ng/ml SDF-1a, 10 ng/ml VEGF, SDF-
1a+VEGF, RAW 264.7 conditioned media, control migration buffer or
complete DMEM added to the lower well. SDF-1a and VEGF were
suspended in serum-free migration buffer. CT26 were allowed to
migrate for 3 hrs at 37uC prior to staining and quantitation of
chemotaxis. Data represents the average6SEM for 15–30 randomly
selected fields over 3–6 separate experiments. * denotes significance
between SDF-1a with VEGF compared to SDF-1a (p,0.05) or VEGF
alone (p,0.05). C) RAW 264.7 (10
5/ml) were added to the upper well of
a Boyden chamber with 40 ng/ml CSF-1, CT26 conditioned media,
control buffer or complete DMEM added to the lower well. CSF-1 was
suspended in serum-free migration buffer. Anti-CSF-1R was present in
both top and bottom wells, as indicated, throughout the assay. RAW
264.7 were allowed to migrate for 24 hrs at 37uC prior to staining and
quantitation of chemotaxis. Data represents average6SEM for 15–30
randomly selected fields over 3–6 separate experiments. #denotes
significance between CSF-1 and CSF-1+anti-CSF-1R (p,0.0001).
##denotes significance between CT26 CM and CT26 CM+anti-CSF-
1R (p,0.0001).
doi:10.1371/journal.pone.0006713.g004
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density and vascular disruption.
Analysis of Macrophage Localization in CT26 tumors In
Vivo
Published data suggests that macrophages are recruited to sites of
solid tumor formation in vivo in response to soluble cues [13,33].
However, the location and distribution of macrophages within the
tumor proper and surrounding microenvironment is still not clear.
Existing work indicates that macrophages target the outer perimeter
of the tumor where they contribute to cancer invasion and
angiogenesis [7]. However, TAMs also may localize within the
tumor interior where they are believed to facilitate the removal of
dead cells and debris [13]. To examine the distribution of RAW
264.7 macrophages in the CT26 tumor in the CAM model,
macrophages and CT26 cellswere transfected with GFP and DsRed,
respectively, and co-transplanted onto chick CAMs. Following 11
days of incubation, the tumors were surgically removed, weighed,
Figure 5. RAW 264.7 macrophages promote CT26 tumor formation, metastasis and neovascularization in the chick CAM. A) CT26-
DsRed (1.8610
6 cells) alone or together with RAW 264.7-GFP (2610
5 cells) were suspended in Matrigel then inoculated onto the chick CAM. After 11
days, the primary tumors were imaged at 0.63X and 2X by stereomicroscopy then removed, weighed and measured. Images are representative of
tumors from 7–10 separate experiments. Magnification scale bar for the 0.63X images represents 3 mm. Magnification scale bar for the 2X images
represents 1 mm. B) CT26 metastasis was quantitated by counting the cell clusters present in the chick lungs using confocal microscopy at 10X. Data
represents the average6SEM for 14–16 lungs over 4–6 separate experiments. * denotes significance between primary tumors with CT26 alone
compared to primary tumors with CT26 and RAW 264.7 (p,0.01). Explanted tumors were also analyzed for weight and volume. Data represents the
average6SEM for 7–10 tumors over 4–6 separate experiments. ** denotes significance in weight between primary tumors with CT26 alone compared
to primary tumors with CT26 and RAW 264.7 (p,0.001). *** denotes significance in volume between primary tumors with CT26 alone compared to
primary tumors with CT26 and RAW 264.7 (p,0.001).
doi:10.1371/journal.pone.0006713.g005
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the imaging chamber. Confocal images were then collected
sequentially from the tumor border to the central core of the tumor
using a 10X objective. Quantitation of macrophage distribution was
determined by calculating average GFP pixel intensity present in
each tumor region. As shown in Fig. 6, RAW 264.7 macrophages
Figure 6. Analysis of Macrophage Localization in CT26 tumors In Vivo. A) CT26-DsRed (1.8610
6 cells) together with RAW 264.7-GFP (2610
5
cells) were suspended in Matrigel then inoculated onto the CAM of chick embryos for 11 days. After 11 days, the primary tumors were sectioned and
imaged at 10X across the Z-axis using confocal microscopy. Tumors were imaged 0 to 0.5 cm from the periphery (Tumor Periphery), 0.5 cm to 1 cm
from the periphery (Tumor Wall) and 1.0 cm to 3 cm from the tumor periphery (Tumor Core). Images are representative of tumors from 7–10
separate experiments. Magnification scale bar represents 200 mm. B) RAW 264.7-GFP distribution within the CT26-DsRed tumors was determined by
averaging pixel bit maps to produce a mean fluorescence intensity for each region of the tumor. Data represents the average6SEM for RAW 264.7-
GFP distribution in tumors from 3 separate experiments. * denotes significance in pixel intensity between the tumor periphery region and the tumor
wall region (p,0.001). C) CT26 and human breast cancer lines CL16, metastatic variant of MDA-MD-435 and MDA-MB-468 were incubated in 1% O2
for 24 hrs in standard media prior to mRNA extraction and qPCR. CSF-1 mRNA expression under hypoxic conditions is presented as a percentage of
basal expression under normoxic conditions. HPRT-1 was used to normalize by global gene expression. Data represents the average6SEM from 3
separate experiments. D) RAW 264.7 (2610
5 cells) were added to the upper well of a Boyden chamber with complete DMEM added to the lower well.
RAW 264.7 were allowed to migrate for 24 hrs at 37uC under normoxic (21% oxygen) or hypoxic (1% oxygen) conditions prior to crystal violet staining
and quantitation of chemotaxis by absorbance at 570 nm. Data represents average6SEM for 15–30 randomly selected fields over 3 separate
experiments. ** denotes significance between RAW 264.7 chemotaxis during hypoxic and normoxic conditions (p,0.05).
doi:10.1371/journal.pone.0006713.g006
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macrophages observed in the region 0.5–1 cm from the tumor
border. Moreover, no macrophages were observed in the center of
the tumor, suggesting specific migration of macrophages towards
CT26 cells residing at or near the tumor border.
Tumor Cell Hypoxia Regulates Expression of CSF-1
While the role of hypoxia in regulation of CSF-1 expression has
not been previously determined, we hypothesized that CSF-1
levels may be higher at the tumor margin where invading cells are
exposed to an oxygen-rich environment compared to the hypoxic
tumor core. To investigate this hypothesis, CSF-1 mRNA levels
were quantified in CT26 cells cultured for 24 hours under
normoxic or hypoxic conditions. Hypoxia caused a significant
reduction in CSF-1 mRNA levels compared to normoxic cells
(Fig. 6C). Similarly, MDA-MB-468 breast carcinoma cell and
metastatic CL16 cancer cells, which are derived from MDA-MB-
435 cells, also demonstrated decreased CSF-1 gene expression
when switched from normoxic to hypoxic conditions, suggesting
that this response may be widespread amongst various types of
cancer. As anticipated, hypoxic conditions did not change the level
of GAPDH or HPRT-1 in the tumor cells, which served as
internal controls (results not shown). Numerous chemokine and
survival promoting genes have been reported to be upregulated by
tumor cells exposed to hypoxic conditions [38]. Thus, we
hypothesize that the selective localization of RAW 264.7
macrophages to the tumor periphery occurs in response to a
CSF-1 gradient generated between hypoxic and the normoxic
regions of the tumor. In support of this contention, RAW 264.7
macrophages do not migrate effectively under hypoxic conditions
characteristic of the tumor core microenvironment (Fig. 6D).
Together, the data presented here suggest a preliminary model
where macrophages home to the tumor periphery during the early
stages of tumor growth in response to CSF-1 released by normoxic
tumor cells. This generalized model for how macrophages regulate
tumor progression is the basis for ongoing research and is
summarized schematically in Figure 7.
Discussion
The present study introduces a simple and genetically tractable
system to decipher the complex bidirectional chemokine signaling
between macrophages and tumor cells in vitro and in vivo. Through
the use of the CT26 tumor cell/RAW 264.7 macrophage
combination, our objectives were to investigate the chemotactic
and angiogenic nature of the interaction then perform an analysis
of the inflammatory genes that are up- or down-regulated during
these responses. By this approach, the expectation was that the
microarray analysis would then serve as a resource for identifying
and testing specific signaling pathways activated in alternative
macrophage/tumor cell interactions during cancer progression. In
this work we show that, (1) soluble RAW 264.7 macrophage-
Figure 7. Proposed model for the role of tumor associated macrophages in cancer progression. During tumor growth, macrophages
home to normoxic regions at the tumor periphery in response to secreted CSF-1. The macrophages in turn release soluble chemokines that stimulate
the tumor cells to release more CSF-1 creating a localized high concentration of CSF-1 that promotes further macrophage infiltration and survival at
the tumor periphery. The close proximity of macrophages and tumor cells establishes a paracrine chemokine network at the tumor margin that
results is at least two major outcomes. First, tumor cell migration and tissue invasion increases as the result of SDF-1a and VEGF release by tumor
associated macrophages. Second, both tumor cells and macrophages are stimulated to release VEGF and TGFb, which facilitates vessel growth,
remodeling, and increased permeability. The increase in tumor cell invasiveness combined with structural changes in the surrounding vasculature
provides optimal conditions for tumor cell intravasation and metastasis.
doi:10.1371/journal.pone.0006713.g007
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tumor cell chemotaxis in vitro and metastasis in vivo, (2) in response
to CT26 tumor cell conditioned media, RAW 264.7 macrophages
adopt an alternative phenotype characterized by upregulation of
numerous chemotactic cytokines and angiogenic growth factors,
including TGF-b, VEGF, CXCL2 and SDF-1a, (3) in response to
RAW 264.7 macrophage conditioned media, tumor cells also
upregulate numerous chemotactic cytokines and angiogenic
factors, including CCL2, CSF-1, CSF-2 and VEGF, (4) RAW
264.7 macrophages are highly chemotactic to tumor derived CSF-
1, whereas CT26 tumor cells in this system chemotax to a
combination of VEGF and SDF-1a but not EGF, (5) using the
chick CAM as a model of the in vivo environment, RAW 264.7
macrophages localize to the tumor periphery where they
potentiate CT26 tumor cell metastasis and neovascularization,
(6) CT26 tumor cells exposed to hypoxia downregulate CSF-1
expression, suggesting a preliminary mechanism for macrophage
homing to the tumor periphery rather than the tumor core.
The ability to use the RAW 264.7 cell line is advantageous, as
these cells provide a high level of reproducibility compared to
freshly isolated monocytes/macrophages and they can be grown in
large numbers, which is amenable to large-scale biochemical and
proteomic studies. Also, the Alliance for Cellular Signaling (AfCS;
www.afcs.org) is generating a comprehensive and systematic
profile of chemokine signaling using the RAW 264.7 cell line.
Thus, the system wide efforts by the AfCS combined with the
cancer model developed here could provide new insights into the
complex communication networks that exist between macrophag-
es and tumor cells. Moreover, the ability to extend these findings in
vivo using the CAM cancer model and genetically tractable cell
lines could help identify important signaling programs that operate
in live animals. The CAM assay is widely used to study cancer
progression model and others have engrafted tumor cells and
exogenous immune cells onto the CAM tissue to investigate the
role of MMPs in cancer and angiogenesis [39].
The current work demonstrates quantitatively that RAW 264.7
macrophages can increase CT26 cancer cell invasiveness in vitro
and in vivo. This corroborates an accumulating body of evidence
that macrophages contribute to cancer cell dissemination [2].
Although the precise mechanism is not understood, our findings
indicate that SDF-1a and VEGF are two macrophage-derived
chemokines that can increase tumor cell migration. Interestingly,
activation of the migration machinery required both chemokines
to be present, as neither SDF-1a nor VEGF alone could induce
CT26 movement. This suggests that co-signaling from CXCR4
(SDF-1a receptor) and the tyrosine kinase VEGF receptor(s) are
necessary to drive cell migration in this system. While previous
work has demonstrated an important role for SDF-1a in mediating
colon cancer cell migration and metastasis and VEGF has been
previous linked to cell migration, to our knowledge this is the first
observation that these two chemokines may be cooperative in the
induction of cancer cell migration [35,40].
Our findings indicate that CT26 colon cancer cells secrete CSF-
1 which serves as strong RAW 264.7 macrophage chemoattrac-
tant. This work is in agreement with previous studies that have
shown that CSF-1 secretion by breast cancer cells is a potent
chemoattractant for macrophages in vitro and in vivo [33,34,37].
While these studies clearly show that tumor derived CSF-1 can
direct macrophage migration and infiltration into the tumor,
several important questions remain. What regulates CSF-1 release
by tumor cells? Our findings indicate that there is a basal level of
CSF-1 production by CT26 tumor cells that is sufficient to attract
RAW 264.7 macrophages. This appears to be regulated by oxygen
tension, as several tumor cell lines cultured under hypoxic
conditions downregulated CSF-1 gene expression. To our
knowledge this is the first demonstration showing that hypoxia
regulates CSF-1 expression in tumor cells. Importantly, our gene
array findings indicate that RAW 264.7 macrophage-derived
chemokines upregulate CSF-1 production by CT26 tumor cells.
This suggests that a positive feedback loop may exists between
resident TAMs and tumor cells to maintain a locally high
concentration of CSF-1. Such a bidirectional signal could then
serve to maintain a large population of highly activated
macrophages in close proximity to growing tumor cells. Thera-
peutic targeting of this communication network could be exploited
as a means to slow cancer progression.
Where in the tumor proper do macrophages localize? Our
findings and work by others indicate that RAW 264.7 macro-
phages can accumulate in the invasive zone of the advancing
tumor [7]. This area of the tumor is thought to be well oxygenated
compared to the tumor core. Combined with our result showing
downregulation of CSF-1 expression by hypoxic tumor cells, we
hypothesize that high oxygen tension at the tumor periphery and
low oxygen tension at the tumor core create a chemoattractant
gradient of CSF-1. While preliminary, this mechanism could
direct macrophages to the tumor edge where they further amplify
CSF-1 concentrations through positive feedback mechanisms as
discussed above. In addition, RAW 264.7 macrophages show
reduced ability to migrate under hypoxic conditions, which further
supports macrophage localization to the tumor edge and not the
hypoxic tumor core. This hypothesis is the focus of ongoing
studies.
What are the consequences of macrophages accumulating at the
edge of the advancing tumor? Our findings indicate that vascular
remodeling and increased metastasis are important consequences
of this process. We observed that the RAW 264.7 macrophages
induced a dramatic increase the microvascular density surround-
ing the CT26 tumor. In fact, the vessels were so disrupted and
leaky that it precluded direct enumeration of vessel changes.
Although the angiogenic mechanisms that generate this type of
response have not been fully elucidated, previous studies have
shown that both tumor cells and TAMs express VEGF [35,41].
Corroborating these studies, we found that the interaction of
CT26 tumor cells and RAW 264.7 macrophages increased VEGF-
A gene expression by both the CT26 cells and RAW 264.7
macrophages under normoxic conditions. This suggests that the
paracrine signaling between tumor cells and TAMs may be
sufficient to induce the release of angiogenic factors in the absence
of hypoxia. The resulting high concentration of VEGF would be
expected to drive vascular remodeling and permeability which in
turn provides an environment rich for tumor growth and
metastasis. In fact, disrupted neovasculature has been shown to
provide portholes for invasive cancer cells to access the vascular
compartment [12]. This combined with the known ability of
TAMs to secrete extracellular matrix proteases leading to
increased tumor cell invasion could account for the increased cell
metastasis associated with TAM infiltration [42].
Based on our findings and the work of others we propose a
hypothetical model in which normoxic invasive tumor cells release
CSF-1 into the extracellular environment creating a chemokine
gradient that immobilizes monocytes/macrophages to the invasive
tumor edge (Fig. 7). This in turn stimulates the release of
macrophage derived chemokines, including SDF-1a and VEGF,
which increase tumor cell migration/invasion, angiogenesis, and
vascular disruption. Ultimately, the destabilized vasculature
combined with increased tumor cell invasion provides an
environment rich for cancer metastasis. The development of
relevant and tractable model systems, as described in the present
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PLoS ONE | www.plosone.org 13 August 2009 | Volume 4 | Issue 8 | e6713study, not only improve our understanding of metastasis, but may
also aid in the design and testing of therapeutics that target
metastatic cells and/or the macrophages that contribute to cancer
cell dissemination in vivo. We propose that data generated in the
current study be used as a community resource for the further
examination of inflammatory pathways in the other macrophage/
tumor cell systems. Validation of these chemical networks will be
necessary to determine if redundant mechanisms exist and
therapeutics can be developed to target the spectrum of human
cancers.
Supporting Information
Figure S1 Hierarchical clustering of gene transcripts upregu-
lated and downregulated by RAW 264.7 macrophages in CT26
conditioned buffer. CT26 conditioned buffer was applied to RAW
264.7 macrophages for 24 hrs prior to mRNA isolation and
analysis using the Codelink Mammalian Inflammation Bioarray.
Significance of transcript upregulation or downregulation was
determined using the VAMPIRE statistical algorithm. Of the 854
inflammatory genes examined, 270 were differentially expressed
(Supplementary Table S1). Hierarchical clustering of this
subpopulation was performed using dChip (distance: correlation,
linkage: centroid) based on the gene ontology annotations for A)
cell proliferation, B) angiogenesis and C) chemotaxis. Red bars
and green bars denote upregulated and downregulated genes,
respectively. D) For heatmap analysis, intensity scores were
calculated based on the significance of gene up- or down-
regulation, as determined by VAMPIRE analysis. These genes
were then organized based on the gene ontology annotations for
angiogensis, cell proliferation and chemotaxis using dChip
(distance metric: correlation, linkage method: average). Each
column in the heatmap represents an independent replicate of
RAW 264.7 in CT26 conditioned buffer or RAW 264.7 in
standard control buffer, as indicated.
Found at: doi:10.1371/journal.pone.0006713.s001 (2.31 MB TIF)
Figure S2 Hierarchical clustering of gene transcripts upregu-
lated and downregulated by CT26 tumor cells in RAW 264.7
conditioned buffer. RAW 264.7 conditioned buffer was applied to
CT26 tumor cells for 24 hrs prior to mRNA isolation and analysis
using the Codelink Mammalian Inflammation Bioarray. Signifi-
cance of transcript upregulation or downregulation was deter-
mined using the VAMPIRE statistical algorithm. Of the 854
inflammatory genes examined, 85 were differentially expressed
(Supplementary Table S2). Hierarchical clustering of this
subpopulation was performed using dChip (distance: correlation,
linkage: centroid) based on the gene ontology annotations for A)
angiogensis, B) cell proliferation and C) chemotaxis. Red bars and
green bars denote upregulated and downregulated genes,
respectively. D) For heatmap analysis, intensity scores were
calculated based on the significance of gene up- or down-
regulation, as determined by VAMPIRE analysis. These genes
were then organized based on the gene ontology annotations for
angiogensis, cell proliferation and chemotaxis using dChip
(distance metric: correlation, linkage method: average). Each
column in the heatmap represents an independent replicate of
CT26 tumor cells in RAW 264.7 conditioned buffer or CT26 in
standard control buffer, as indicated.
Found at: doi:10.1371/journal.pone.0006713.s002 (1.95 MB TIF)
Table S1 Microarray analysis of inflammatory gene expression
in RAW 264.7 macrophages during incubation in CT26 tumor
cell conditioned buffer. To examine inflammatory gene expres-
sion, conditioned buffer was collected from CT26 cultures
following 48 hrs of incubation at 37uC and applied to RAW
264.7 cultures for an additional 24 hrs at 37uC. mRNA was then
isolated, reverse transcribed and analyzed by hybridization to the
Codelink Mammalian Inflammation Bioarray (GE Healthcare,
Piscataway, NJ), according to the manufacturer recommendations.
Significance of transcript upregulation or downregulation was
determined using the VAMPIRE statistical algorithm. Data
represents the fold change in transcript expression from 3 separate
experiments. Of the 854 genes assayed, 270 genes were
determined to be significantly upregulated or downregulated in
RAW 264.7 macrophages during culture in CT26 conditioned
buffer.
Found at: doi:10.1371/journal.pone.0006713.s003 (0.35 MB
DOC)
Table S2 Microarray analysis of inflammatory gene expression
in CT26 tumor cells during incubation in RAW 264.7
macrophage conditioned buffer. To examine inflammatory gene
expression, conditioned buffer was collected from RAW 264.7
cultures following 48 hrs of incubation at 37uC and applied to
CT26 cultures for an additional 24 hrs at 37uC. mRNA was then
isolated, reverse transcribed and analyzed by hybridization to the
Codelink Mammalian Inflammation Bioarray (GE Healthcare,
Piscataway, NJ), according to the manufacturer recommendations.
Significance of transcript upregulation or downregulation was
determined using the VAMPIRE statistical algorithm. Data
represents the fold change in transcript expression from 3 separate
experiments. Of the 854 genes assayed, 85 genes were determined
to be significantly upregulated or downregulated in CT26 cells
during culture in RAW 264.7 conditioned buffer.
Found at: doi:10.1371/journal.pone.0006713.s004 (0.12 MB
DOC)
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